Compare · CHE vs EUDA
CHE vs EUDA
Side-by-side comparison of Chemed Corp (CHE) and EUDA Health Holdings Limited (EUDA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHE and EUDA operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE is the larger of the two at $7.11B, about 164.9x EUDA ($43.1M).
- Over the past year, CHE is up 22.0% and EUDA is down 63.4% - CHE leads by 85.5 points.
- CHE has been more active in the news (7 items in the past 4 weeks vs 3 for EUDA).
- CHE has more recent analyst coverage (6 ratings vs 0 for EUDA).
PerformanceCHE+22.02%EUDA-63.44%
2025-08-26+0.00%2026-08-25
- Company
- Chemed Corp
- EUDA Health Holdings Limited
- Price
- $545.01+0.91%
- $16.60+10.52%
- Market cap
- $7.11B
- $43.1M
- 1M return
- +7.23%
- +10.52%
- 1Y return
- +22.02%
- -63.44%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 7
- 3
- Recent ratings
- 6
- 0
CHE
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Latest CHE
- Executive vice president Lee Spencer S sold $541,040 worth of Capital Stock (1,000 units at $541.04), decreasing direct ownership by 7% to 13,912 units (SEC Form 4)
- President and CEO Mcnamara Kevin J sold $1,082,320 worth of Capital Stock (2,000 units at $541.16), decreasing direct ownership by 3% to 70,418 units (SEC Form 4)
- VP and Chief Legal Officer Judkins Brian C exercised 6,786 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 5,878 units of Capital Stock, increasing direct ownership by 37% to 3,344 units (SEC Form 4)
- CEO - Vitas Healthcare Wherley Joel L exercised 2,599 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 2,270 units of Capital Stock, increasing direct ownership by 39% to 1,181 units (SEC Form 4)
- Chemed Corporation Declares Quarterly Dividend of 70 Cents
- President and CEO Mcnamara Kevin J covered exercise/tax liability with 19,802 units of Capital Stock, sold $1,079,020 worth of Capital Stock (2,000 units at $539.51) and exercised 2,001 units of Capital Stock at a strike of $445.35, decreasing direct ownership by 22% to 70,418 units (SEC Form 4)
- Director Grace Patrick P sold $101,080 worth of Capital Stock (190 units at $532.00), decreasing direct ownership by 5% to 3,533 units (SEC Form 4)
- SEC Form 10-Q filed by Chemed Corp
- Chemed Corp filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Chemed Reports Second-Quarter 2026 Results
Latest EUDA
- EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore
- SEC Form 424B3 filed by EUDA Health Holdings Limited
- SEC Form EFFECT filed by EUDA Health Holdings Limited
- Amendment: SEC Form F-3/A filed by EUDA Health Holdings Limited
- SEC Form 6-K filed by EUDA Health Holdings Limited
- EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products
- SEC Form 6-K filed by EUDA Health Holdings Limited
- EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies
- SEC Form 424B5 filed by EUDA Health Holdings Limited
- Amendment: SEC Form F-3/A filed by EUDA Health Holdings Limited